Trade Tools The gekoTM medical device – an
alternative for the prevention of Deep Vein Thrombosis
Vexim Cohesion® Cohesion® Bone Cement Bone Cement is a PolyMethyl MethAcrylat (PMMA)
implant with specifi c and unique prop- erties used for the Fixa- tion of fractured vertebral bodies. Especially in the case of com- plex fragmented fractures with underlying pathologies aff ecting bone quality, it is of utmost importance to have a full control over the cement injection and reliable long term results through:
• Appropriate high viscosity The Cohesion®
Bone Cement has been formulated to reach
an optimal viscosity of a minimum 350 Pa.s at injection time, allowing the cement to create a sphere-shape, important to avoid leakage.
The gekoTM from Firstkind is an innovative device for the pre-
vention of Deep Vein Thrombosis. The device, which is at- tached to the back of the knee is designed to increase blood circulation to a rate of up to 70% through neuromuscular elec- tro-stimulation. A recent clinical assessment, conducted by John Fletcher,
Professor of Surgery, University of Sydney and Westmead Hospital, Australia has endorsed the gekoTM
device as ideal for
post-surgical applications. “There is a defi nite need to have a better way of dealing with patients that are contraindicated to current standard prophylactic modalities and are at high risk of DVT,” Fletcher said. “And this device certainly has the potential to fulfi l this need.” The gekoTM
device was developed in the UK following re-
search at St Bartholomew’s Hospital and William Harvey Re- search Institute, Queen Mary, University of London, led by Ar- thur Tucker and Duncan Bain. The gekoTM
FDA and is unavailable for sale in the USA.
Firstkind Limited +44 (0)1494 572 040 info@fi
rstkindmedical.com www.gekodevices.com
Vexim Tel: +33 5 61 48 86 Email:
vexim@vexim.fr Web:
www.vexim.com
• Sustained high viscosity Cohesion®
Bone Cement has been designed to allow an ap-
propriate preparation - while avoiding any waiting time. The injection or dough phase has been designed to be exception- ally long, nearly 18 minutes at 18°c for a comfortable manage- ment of the fi xation phase.
• High Radio-opacity With 45% of Zirconium oxide as radio-opacifi ant, Cohesion® Bone Cement has been formulated to provide state- of-the-art visibility while being injected.
Long term results Based on more than 50 years of excellent PMMA clinical history, Cohesion®
Bone Cement, is a fully biocom- patible implant made with the latest generation of compounds. Cohesion®
Jack® device is CE marked, but is not cleared by the ment interdigitation.
Bone Cement along with the use of Vexim’s Spine- system both preserve bone trabeculae and improve ce-
REAL TIME Intraoperative Implant Verifi cation
InCT™: fast, low radiation, intra-operative verifi cation of implant placement, based on standard OR equipment. Mazor Robotics’ InCT™, the latest feature of Renaissance™ Surgical Guidance Robot, enables surgeons to intraoperatively verify implant positioning quickly and effi ciently in 3D, while using any standard 2D C-Arm. A 15-second fl uoroscopic scan is taken in the OR immediately after screw positioning (prior to insertion of rods) with a specialised
reference marker (fi ducial array). These images are merged with the pre-op CT, superimposing the screws from the fl uoro scan onto the pre-op CT. This provides accurate and sharp imagery of the implants on the high quality pre-op CT images of the patient, with minimal radiation to the patient and to the OR staff . Because implant revisions should be a thing of the past. Learn more about Renaissance™ Surgical Guidance Robot with InCT™ application at How Robotics is Changing Spine Surgery Symposium at SpineWeek (booth 213).
Mazor Robotics Tel: +972 4 6187 117
Email:
avi.posen@MazorRobotics.com Website:
www.mazorrobotics.com
12 | SpinalSurgeryNews | Autumn 2012
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36